Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Ribosome A-site (Aminoacyl-tRNA site)** is one of the three tRNA binding sites of the ribosome, integral to the process of protein synthesis in all cells[5][7][9]. Situated at the interface of the ribosomal small and large subunits, the A-site accommodates incoming aminoacyl-tRNAs that base-pair with the codon exposed by the ribosome on the mRNA template. Successful pairing at the A-site enables the ribosome's catalytic center to catalyze peptide bond formation, elongating the nascent polypeptide[3][5][7]. The site is central to the fidelity of translation and is the target of a number of important antibacterial drugs that inhibit translation by preventing tRNA accommodation or inducing codon misreading. While the A-site itself is not a molecule or receptor in the classical sense, it is considered a valid therapeutic target within the larger ribosome complex. Nevertheless, the phrase "Ribosome A-site/protein synthesis machinery" is **imprecise**: the A-site is a site within the broader ribosome complex (the canonical therapeutic target would thus be "Ribosome" or, even more precisely, for antibiotics "Bacterial ribosome A-site"). The full protein synthesis machinery comprises many components, including tRNAs, rRNA, and various translation factors[4][5][6][10]. **Notes:** - "Ribosome A-site/protein synthesis machinery" conflates the A-site (a specific functional site) and the entire translation apparatus, which includes many macromolecules. For structured, canonical drug discovery ontologies, designate "Ribosome A-site" as a binding target or "Ribosome" as the molecular complex (with sub-targets as appropriate)[5][7]. - All ribosomes (bacterial, eukaryotic, mitochondrial) have an A-site; drugs generally target bacterial ribosome A-sites for selective antimicrobial action[9].
Inhibition of tRNA binding (blocking aminoacyl-tRNA entry to the A-site); Induction of mRNA misreading; Inhibition of peptide bond formation (indirect, as a consequence of blocked A-site occupancy)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosome A-site.